What are the giant cells characteristic of Hodgkin lymphoma called, specifically Reed-Sternberg (RS) cells?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hodgkin lymphoma is characterized by the presence of giant cells called Reed-Sternberg cells. These cells are a hallmark of the disease and are essential for diagnosis 1. They are large, multinucleated cells with a distinctive appearance, often described as having an "owl-eye" appearance due to prominent nucleoli. Reed-Sternberg cells originate from B lymphocytes that have undergone malignant transformation and are typically surrounded by a mix of inflammatory cells, including lymphocytes, histiocytes, eosinophils, and plasma cells. Some key characteristics of Reed-Sternberg cells include:

  • Large size with multiple nuclei or a bilobed nucleus
  • Prominent nucleoli, giving an "owl-eye" appearance
  • Origin from B lymphocytes that have undergone malignant transformation
  • Typically make up a small percentage of the total cell population in affected lymph nodes The identification of these cells through biopsy and histopathological examination is crucial for distinguishing Hodgkin lymphoma from other lymphoid malignancies and determining appropriate treatment strategies 1. The presence of Reed-Sternberg cells, along with the characteristic inflammatory background, forms the histological basis for diagnosing and classifying the different subtypes of Hodgkin lymphoma.

From the Research

Characteristics of Hodgkin Lymphoma

  • Hodgkin lymphoma (HL) is characterized by the presence of giant multinucleated tumor cells called Hodgkin/Reed-Sternberg (H/RS) cells 2
  • These cells are large, often multinucleated with a peculiar morphology and an unusual immunophenotype, that does not resemble any normal cell in the body 3
  • H/RS cells are the clonal tumour cells of HL and derive from B cells in nearly all cases of HL, with rare cases deriving from T cells 3

Origin of Giant Cells in Hodgkin Lymphoma

  • The development of Reed-Sternberg (RS) cells has remained obscure, but continuous live cell imaging has revealed that RS cells develop from mononucleated progenitors that divide and subsequently re-fuse, before they grow and become multinucleated giant cells 4
  • This process is neither due to cell fusion of unrelated Hodgkin cells nor to endomitosis, as previously suggested 4

Pathogenesis and Immune Response

  • The pathogenesis of HL is still largely unresolved, but aberrant activation of several signalling pathways, such as the NFkappaB pathway, is of key importance for H/RS cell survival 3
  • The presence of an extensive inflammatory infiltrate is a characteristic of classical HL, comprising Th2 and T regulatory cells, and generally lacking Th1 cells, CD8 cytotoxic T cells, and natural killer (NK) cells 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Molecular pathogenesis of Hodgkin lymphoma.

International journal of hematology, 2006

Research

The Hodgkin and Reed/Sternberg cell.

The international journal of biochemistry & cell biology, 2005

Research

On the origin of giant cells in Hodgkin lymphoma.

Communicative & integrative biology, 2014

Research

Immunobiology and pathophysiology of Hodgkin lymphomas.

Hematology. American Society of Hematology. Education Program, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.